GERCOR
Showing 1 - 25 of 121
Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)
Not yet recruiting
- Adenocarcinoma - GEJ
- Gastric Adenocarcinoma
- (no location specified)
Sep 26, 2023
Circulating Tumor DNA in Colorectal Cancer Undergoing
Not yet recruiting
- Metastatic Colorectal Cancer
- Circulating Tumor DNA
-
Besançon, France
- +15 more
Mar 24, 2023
Colorectal Cancer, Liver Cancer, Gastric Cancer Trial in Créteil, Grenoble, Paris (Acupuncture intervention, No acupuncture)
Not yet recruiting
- Colorectal Cancer
- +4 more
- Acupuncture intervention
- No acupuncture
-
Créteil, France
- +4 more
May 12, 2023
Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)
Active, not recruiting
- Neuroendocrine Carcinoma
-
Aix-en-Provence, France
- +6 more
Mar 9, 2022
Colorectal Cancer Trial in Paris (FOLFOX regimen, fluorouracil, leucovorin calcium)
Active, not recruiting
- Colorectal Cancer
- FOLFOX regimen
- +5 more
-
Paris, FranceGERCOR Groupe Cooperateur Multidisciplinaire en Oncologie
Jan 20, 2022
Phenotyping of Small Bowel Adenocarcinoma
Completed
- Small Bowel Adenocarcinoma
- (no location specified)
Jan 12, 2021
Ovarian Cancer, Epithelial Trial in France (CC0 - Carboplatin (IV) - Paclitaxel (IV), CC0 - Cisplatin (IP) - Epirubicin (IV),
Recruiting
- Ovarian Cancer, Epithelial
- CC0 - Carboplatin (IV) - Paclitaxel (IV)
- +3 more
-
Dijon, France
- +6 more
Feb 10, 2021
Localized Oesogastric Adenocarcimona, MSI and or dMMR Trial in France (Nivolumab 10 MG/ML, Ipilimumab 200 MG in 40 ML Injection)
Recruiting
- Localized Oesogastric Adenocarcimona
- MSI and or dMMR
- Nivolumab 10 MG/ML
- Ipilimumab 200 MG in 40 ML Injection
-
Besançon, France
- +14 more
Jun 10, 2021
Metastatic Cancer Colorectal Trial in France (Ipilimumab 200 MG in 40 ML Injection, Nivolumab 10 MG/ML)
Active, not recruiting
- Metastatic Cancer Colorectal
- Ipilimumab 200 MG in 40 ML Injection
- Nivolumab 10 MG/ML
-
Avignon, France
- +7 more
Jan 26, 2021
Metastatic Pancreatic Cancer Trial in France (FOLFIRI.3, nab-paclitaxel+ gemcitabine)
Completed
- Metastatic Pancreatic Cancer
- FOLFIRI.3
- nab-paclitaxel+ gemcitabine
-
Albi, France
- +36 more
Dec 3, 2021
Colorectal Cancer Metastatic, MSI-H Colorectal Cancer Trial in France (Nivolumab, Ipilimumab)
Recruiting
- Colorectal Cancer Metastatic
- MSI-H Colorectal Cancer
-
Avignon, France
- +18 more
Apr 6, 2021
Metastatic Pancreatic Adenocarcinoma Trial in France (Arm A - Olaparib, ARM B - durvalumab plus selumetinib, ARM C FOLFIRI)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Arm A - Olaparib
- +2 more
-
Avignon, France
- +28 more
Dec 29, 2020
Patients With Hepatocellular Carcinoma in France
Recruiting
- Cancer of Liver
- Hepatocellular Carcinoma
-
Amiens, FranceCHU Amiens
Apr 14, 2020
Treatment Response in Patients With Pancreatic Adenocarcinoma
Not yet recruiting
- Pancreatic Adenocarcinoma
-
Besançon, France
- +14 more
Mar 8, 2023
Colorectal Cancer Metastatic Trial in France, Ireland, Israel (FOLFIRI-cetuximab, mFOLFOX6-bevacizumab, OPTIMOX-bevacizumab)
Recruiting
- Colorectal Cancer Metastatic
- FOLFIRI-cetuximab
- +5 more
-
Annecy, France
- +55 more
Jun 11, 2021
Use of Targeted Therapies in Metastatic Colorectal Cancer
Active, not recruiting
- Metastatic Colon Cancer
- Chemotherapy
- Chemotherapy plus monoclonal antibody
-
Alcoy, Alicante, Spain
- +47 more
Mar 15, 2022
OESOPHAGO-GASTRIC CARCINOMA Trial in France, Martinique (Oxaliplatin, 5Fluorouracil bolus, 5Fluorouracil continu)
Recruiting
- OESOPHAGO-GASTRIC CARCINOMA
- Oxaliplatin
- +4 more
-
Paris, Ile De France, France
- +97 more
Mar 23, 2022
Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)
Recruiting
- Colorectal Adenocarcinoma
- Oesogastric
-
Besançon, France
- +10 more
Jan 28, 2022
Cancer, COVID, Solid Tumor Trial in France
Completed
- Cancer
- +8 more
-
Abbeville, France
- +147 more
Mar 23, 2022
Cancer Digestive Trial in Saint-Cloud (NMES)
Not yet recruiting
- Cancer Digestive
- NMES
-
Saint-Cloud, FranceInsitut Curie
Jun 11, 2021
Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)
Not yet recruiting
- Hepatocellular Carcinoma
- +4 more
- Liquid Biopsy
- (no location specified)
Apr 18, 2023
Response to Treatment in Bile Duct Cancer: ACABi PRONOBIL Study
Not yet recruiting
- Biliary Tract Cancer
- (no location specified)
Jun 15, 2021
Research in Patients With Squamous Cell Anal Carcinoma
Withdrawn
- Anal Canal Cancer
- Additional biological samples
-
Besançon, France
- +1 more
Jul 26, 2021